Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid

T Wisniewski, B Frangione - Neuroscience letters, 1992 - Elsevier
T Wisniewski, B Frangione
Neuroscience letters, 1992Elsevier
Many biochemically diverse proteins can give rise to amyloid fibrils; however, they are all
accompanied by P component and glucosaminoglycans. With antibodies specific to
apolipoprotein E (apo E) we used immunohistochemical techniques to test for the presence
of this protein in both cerebral and systemic amyloid. We found apo E immunoreactivity in all
tested types of cerebral and systemic amyloid. In amyloid deposits apo EP, component and
glucosaminoglycans may be acting as 'pathological molecular chaperones'. The latter we …
Abstract
Many biochemically diverse proteins can give rise to amyloid fibrils; however, they are all accompanied by P component and glucosaminoglycans. With antibodies specific to apolipoprotein E (apo E) we used immunohistochemical techniques to test for the presence of this protein in both cerebral and systemic amyloid. We found apo E immunoreactivity in all tested types of cerebral and systemic amyloid. In amyloid deposits apo E P, component and glucosaminoglycans may be acting as ‘pathological molecular chaperones’. The latter we define as a group of unrelated proteins that induce β-pleated conformation in amyloidogenic polypeptides.
Elsevier